CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flow from operating activities:
Net income	$ 8,120	$ 21,148
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	43,373	37,247
Amortization of above and below market leases	90	64
Amortization of deferred loan costs	987	978
Distributions from unconsolidated entity	300
Equity in net loss of unconsolidated entity	677	274
Equity-based compensation expense	4,875	3,300
Bad debt expense	3,719	239
Gain on sale of real estate, net		(13,408)
Deferred tax expense (benefit)	(270)	111
Foreign currency remeasurement income	(159)
Changes in operating assets and liabilities
Rents and other receivables, net	2,888	(2,043)
Prepaid expenses	(3,164)	(2,762)
Due to/from affiliates, net	(4,428)
Other assets	(238)	(419)
Accounts payable and accrued liabilities	7,173	(7,140)
Advance rents, security deposits and other liabilities	6,727	1,653
Deferred income	392	4,926
Net cash provided by operating activities	71,062	44,168
Cash flow from investing activities:
Proceeds from sale of property, net		52,722
Acquisitions, net of cash acquired	(1,797)
Additions to property and equipment	(171,218)	(101,234)
Net cash used in investing activities	(173,015)	(48,512)
Cash flow from financing activities:
Credit facility proceeds	212,917	93,000
Credit facility repayments		(210,000)
Payment of deferred financing costs	(5)	(173)
Payment of preferred stock dividends	(7,045)	(7,045)
Payment of common stock dividends	(25,627)	(20,961)
Distribution to noncontrolling interests	(2,934)	(2,735)
Proceeds from exercise of stock options	808	2,687
Payment of tax withholdings related to equity-based awards	(2,293)	(2,062)
Principal payments on finance lease obligations	(620)	(799)
Mortgage principal debt repayments	(12)	(9)
Common stock issuance proceeds, net of costs	83,260	159,360
Net cash provided by financing activities	258,449	11,263
Effect of foreign currency exchange rates on cash and cash equivalents	(192)
Net change in cash and cash equivalents	156,304	6,919
Cash and cash equivalents, beginning of period	15,653	11,759
Cash and cash equivalents, end of period	171,957	18,678
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest (excluding deferred financing costs and amounts capitalized)	9,370	9,461
Noncash investing and financing activities:
Accrued capital additions	125,750	69,963
Net decrease in other assets/liabilities related to change in fair value of derivative contracts	(35,097)	(9,853)
Equity received in unconsolidated entity in exchange for real estate assets		25,280
Increase in assets in exchange for finance lease obligation		45,024
Accrued equity issuance costs	44	918
Accrued preferred stock dividends	5,938	5,938
Qualitytech, LP
Cash flow from operating activities:
Net income	8,120	21,148
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	43,373	37,247
Amortization of above and below market leases	90	64
Amortization of deferred loan costs	987	978
Distributions from unconsolidated entity	300
Equity in net loss of unconsolidated entity	677	274
Equity-based compensation expense	4,875	3,300
Bad debt expense	3,719	239
Gain on sale of real estate, net		(13,408)
Deferred tax expense (benefit)	(270)	111
Foreign currency remeasurement income	(159)
Changes in operating assets and liabilities
Rents and other receivables, net	2,888	(2,043)
Prepaid expenses	(3,164)	(2,762)
Due to/from affiliates, net	(4,428)
Other assets	(238)	(419)
Accounts payable and accrued liabilities	7,173	(7,140)
Advance rents, security deposits and other liabilities	6,727	1,653
Deferred income	392	4,926
Net cash provided by operating activities	71,062	44,168
Cash flow from investing activities:
Proceeds from sale of property, net		52,722
Acquisitions, net of cash acquired	(1,797)
Additions to property and equipment	(171,218)	(101,234)
Net cash used in investing activities	(173,015)	(48,512)
Cash flow from financing activities:
Credit facility proceeds	212,917	93,000
Credit facility repayments		(210,000)
Payment of deferred financing costs	(5)	(173)
Payment of preferred stock dividends	(7,045)	(7,045)
Payment of cash dividends	(25,627)	(20,961)
Partnership distributions	(2,934)	(2,735)
Proceeds from exercise of stock options	808	2,687
Payment of tax withholdings related to equity-based awards	(2,293)	(2,062)
Principal payments on finance lease obligations	(620)	(799)
Mortgage principal debt repayments	(12)	(9)
Common stock issuance proceeds, net of costs	83,260	159,360
Net cash provided by financing activities	258,449	11,263
Effect of foreign currency exchange rates on cash and cash equivalents	(192)
Net change in cash and cash equivalents	156,304	6,919
Cash and cash equivalents, beginning of period	15,653	11,759
Cash and cash equivalents, end of period	171,957	18,678
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid for interest (excluding deferred financing costs and amounts capitalized)	9,370	9,461
Noncash investing and financing activities:
Accrued capital additions	125,750	69,963
Net decrease in other assets/liabilities related to change in fair value of derivative contracts	(35,097)	(9,853)
Equity received in unconsolidated entity in exchange for real estate assets		25,280
Increase in assets in exchange for finance lease obligation		45,024
Accrued equity issuance costs	44	918
Accrued preferred stock dividends	$ 5,938	$ 5,938